Mutation analysis of LRRK2, SCNA, UCHL1, HtrA2 and GIGYF2 genes in Chinese patients with autosomal dorminant Parkinson's disease

Neuroscience Letters

Volumn 516, Issue 2, 2012, Pages 207-211

  Tian, Jin yong ^a   Guo, Ji feng ^a,c   Wang, Lei ^a   Sun, Qi ying ^a   Yao, Ling yan ^a   Luo, Lin zi ^a   Shi, Chang he ^a   Hu, Ya cen ^a   Yan, Xin xiang ^a,c   Tang, Bei sha ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b State Key Laboratory of Medical Genetics of China   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Autosomal dorminant Parkinson's disease; GIGYF2; HtrA2; LRRK2; SCNA; UCHL1

Indexed keywords

LEVODOPA;

ARTICLE; AUTOSOMAL DOMINANT PARKINSON DISEASE; AUTOSOMAL DORMINANT PARKINSON DISEASE; CHINESE; CLINICAL ARTICLE; ESSENTIAL TREMOR; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GIGYF2 GENE; HTRA2 GENE; HUMAN; LRRK2 GENE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCNA GENE; UCHL1 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; HUMANS; MITOCHONDRIAL PROTEINS; PARKINSONIAN DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SODIUM CHANNELS; UBIQUITIN THIOLESTERASE;

EID: 84860470675     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.086     Document Type: Article

References (32)

1. Athanassiadou A., Voutsinas G., Psiouri L., Leroy E., Polymeropoulos M.H., Ilias A., Maniatis G.M., Papapetropoulos T. Genetic analysis of families with Parkinson disease that carry the ala53-to-thr mutation in the gene encoding alpha-synuclein. American Journal of Human Genetics 1999, 65:555-558.
2. Bonifati V. Is GIGYF2 the defective gene at the PARK11 locus. Current Neurology and Neuroscience Reports 2009, 9:185-187.
3. Choi J.M., Woo M.S., Ma H.I., Kang S.Y., Sung Y.H., Yong S.W., Chung S.J., Kim J.S., Shin H.W., Lyoo C.H., Lee P.H., Baik J.S., Kim S.J., Park M.Y., Sohn Y.H., Kim J.H., Kim J.W., Lee M.S., Lee M.C., Kim D.H., Kim Y.J. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 2008, 9:263-269.
4. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., .Sampaio C., Meco G., Barbosa E., Oostra B.A., Bonifati V. Italian Parkinson genetics network, a frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415.
5. Di Fonzo A., Wu Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohe C.F., Chang H.C., Chen R.S., Weng Y.H., Vanacore N., Breedveld G.J., Oostra B.A., Bonifati V. A common missense variant in the LRRK2 gene, gly2385-to-arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7:133-138.
6. Farrer M., Wavrant-De Vrieze F., Crook R., Boles L., Perez-Tur J., Hardy J., Johnson W.G., Steele J., Maraganore D., Gwinn K., Lynch T. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Annals of Neurology 1998, 43:394-397.
7. Funayama M., Hasegawa K., Ohta E., Kawashima N., Komiyama M., Kowa H., Tsuji S., Obata F. An LRRK2 mutation as a cause for the Parkinsonism in the original PARK8 family. Annals of Neurology 2005, 57:918-921.
8. Healy D.G., Abou-Sleiman P.M., Casas J.P., Ahmadi K.R., Lynch T., Gandhi S., Muqit M.M., Foltynie T., Barker R., Bhatia K.P., Quinn N.P., Lees A.J., Gibson J.M., Holton J.L., Revesz T., Goldstein D.B., Wood N.W. Wood UCHL-1 is not a Parkinson's disease susceptibility gene. Annals of Neurology 2006, 59:627-633.
9. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson s disease: a clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery and Psychiatry 1992, 55:181-184.
10. Ishihara L., Gibson R.A., Warren L., Amouri R., Lyons K., Wielinski C., Hunter C., Swartz J.E., Elango R., Akkari P.A., Leppert D., Surh L., Reeves K.H., Thomas S., Ragone L., Hattori N., Pahwa R., Jankovic J., Nance M., Freeman A., Gouider-Khouja N., Kefi M., Zouari M., Ben Sassi S., Ben Yahmed S., El Euch-Fayeche G., Middleton L., Burn D.J., Watts R.L., Hentati F. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Movement Disorders 2007, 22:55-61.
11. Josephs K.A., Matsumoto J.Y., Ahlskog J.E. Benign tremulous Parkinsonism. Archives of Neurology 2006, 63:354-357.
12. Ki C.S., Stavrou E.F., Davanos N., Lee W.Y., Chung E.J., Kim J.Y., Athanassiadou A. The ala53thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease. Clinical Genetics 2007, 71:471-473.
13. Lautier C., Goldwurm S., Durr A., Giovannone B., Tsiaras W.G., Pezzoli G., Brice A., Smith R.J. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. American Journal of Human Genetics 2008, 82:822-833.
14. Lesage S., Ibanez P., Lohmann E., Pollak P., Tison F., Tazir M., Leutenegger A.L., Guimaraes J., Bonnet A.M., Agid Y., Dürr A., Brice A. French Parkinson's disease genetics study group, G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Annals of Neurology 2005, 58:784-787.
15. Lesage S., Leclere L., Lohmann E., Borg M., Ruberg M., Dürr A., Brice A. French Parkinson's disease genetics study group, frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease. Neuro-degenerative Diseases 2007, 4:195-198.
16. Lin C.H., Tzen K.Y., Yu C.Y., Tai C.H., Farrer M.J., Wu R.M. LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies. Journal of Biomedical Science 2008, 15:661-667.
17. Louis E.D., Vonsattel J.P., Hong L.S., Ross G.W., Lyons K.E., Pahwa R. Essential tremor pathology: a case-control study from the essential tremor centralized brain repository. Movement Disorders 2005, 20:1241.
18. Maraganore D.M., Harding A.E., Marsden C.D. A clinical and genetic study of familial Parkinson's disease. Movement Disorders 1991, 6:205-211.
19. Mata I.F., Kachergus J.M., Taylor J.P., Lincoln S., Aasly J., Lynch T., Hulihan M.M., Cobb S.A., Wu R.M., Lu C.S., Lahoz C., Wszolek Z.K., Farrer M.J. LRRK2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005, 6:171-177.
20. Orr-Urtreger A., Shifrin C., Rozovski U., Rosner S., Bercovich D., Gurevich T., Yagev-More H., Bar-Shira A., Giladi N. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?. Neurology 2007, 69:1595-1602.
21. Pagan F.L., Butman J.A., Dambrosia J.M., Hallett M. Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 2003, 60:1344-1347.
22. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:575-577.
23. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
24. Simon-Sanchez J., Singleton A.B. Sequencing analysis of OMI/HtrA2 shows previously reported pathogenic mutations in neurologically normal controls. Human Molecular Genetics 2008, 17:1988-1993.
25. Shahed J., Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism and Related Disorders 2007, 13:67-76.
26. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., Kruger R. Loss of function mutations in the gene encoding OMI/HtrA2 in Parkinson's disease. Human Molecular Genetics 2005, 14:2099-2111.
27. Spira P.J., Sharpe D.M., Halliday G., Cavanagh J., Nicholson G.A. Clinical and pathological features of a Parkinsonian syndrome in a family with an ala53-to-thr alpha-synuclein mutation. Annals of Neurology 2001, 49:313-319.
28. Vaughan J.R., Farrer M.J., Wszolek Z.K., Gasser T., Durr A., Agid Y., Bonifati V., DeMichele G., Volpe G., Lincoln S., Breteler M., Meco G., Brice A., Marsden C.D., Hardy J., Wood N.W. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. Human Molecular Genetics 1998, 7:751-753.
29. Wang L., Guo J.F., Nie L.L., Xu Q., Zuo X., Sun Q.Y., Yan X.X., Tang B.S. A novel LRRK2 mutation in a Mainland Chinese patient with familial Parkinson's disease. Neuroscience Letters 2010, 468:198-201.
30. Wang L., Guo J.F., Zhang W.W., Xu Q., Zuo X., Shi C.H., Luo L.Z., Liu J., Hu L., Hu Y.C., She L., Jiang H., Yan X.X., Xia K., Pan Q., Tang B.S. Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population. Neuroscience Letters 2010, 20:131-135.
31. Zhang J., Hattori N., Giladi N., Mizuno Y. Failure to find mutations in ubiquitin carboxy-terminal hydrolase L1 gene in familial Parkinson's disease. Parkinsonism and Related Disorders 2000, 6:199-200.
32. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., .Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal dominant Parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.